Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-p-camps
2. (rp)-camps
3. 3,5'-camps
4. Adenosine 3',5'-cyclic Monophosphorothioate
5. Adenosine 3',5'-monothionophosphate
6. Adenosine-3',5'-cyclic Phosphorothioate
7. Adenosine-3',5'-monophosphorothioate
8. Cyclic Adenosine 3,'5'-phosphorothioate
9. Cyclic Apt
10. P-adenosine 3',5'-cyclic Phosphorothiate
11. R(p)-camps
12. Rp-camp-s
13. Sp-camp-s
1. (rp)-camps
2. Cyclic Apt
3. Rp-camps
4. Adenosine-3',5'-cyclic Phosphorothioate
5. 23645-17-2
6. (sp)-camps
7. Chebi:84615
8. Chebi:84622
9. Adenosine-3',5'-cyclic -monophosphorothioate
10. 71774-13-5
11. Rp-camp-s
12. Sp-camp-s
13. (r)-p-camps
14. 3,5'-camps
15. Sp-adenosine-3',5'-cyclic-monophosphorothioate
16. Rp-adenosine 3',5'-cyclic Monophosphorothioate, Sodium Salt
17. R(p)-camps
18. Adenosine 3',5'-monothionophosphate
19. Adenosine-3',5'-monophosphorothioate
20. 6-(6-amino-purin-9-yl)-2-thioxo-tetrahydro-2-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol
21. Cyclic Adenosine 3,'5'-phosphorothioate
22. P-adenosine 3',5'-cyclic Phosphorothiate
23. Adenosine 3',5'-cyclic Monophosphorothioate
24. 73208-40-9
25. Adenosine, Cyclic 3',5'-(hydrogen Phosphorothioate)
26. Gtpl5262
27. Schembl4159569
28. Chembl1235719
29. Chembl1236010
30. Schembl22370431
31. Dtxsid20178316
32. Chebi:191063
33. Adenosine 3',5'-thiophosphoric Acid
34. Db01790
35. Hy-100530a
36. Hy-100530b
37. Ncgc00182722-01
38. Ncgc00485585-01
39. (4ar,6r,7r,7as)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
40. Cs-0019676
41. Cs-0107084
42. (rp)-adenosine-3',5'-cyclic Monophosphorothioate
43. (sp)-adenosine-3',5'-cyclic Monophosphorothioate
44. Q27088619
45. Q27157921
46. Rp-adenosine-3',5'-cyclic-monophosphorothioate
47. Adenosine-3',5'-cyclic Monophosphorothioate, Rp-isomer
48. Adenosine-3',5'-cyclic Monophosphorothioate, Sp-isomer
49. Adenosine, Cyclic 3',5'-[hydrogen [p(s)]-phosphorothioate]
50. Adenosine- 3', 5'- Cyclic Monophosphorothioate, Rp- Isomer
51. (2r,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2h,4h-2lambda(5)-furo[3,2-d][1,3,2]dioxaphosphinin-2-one
52. (2r,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide
53. (2s,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2h,4h-2lambda(5)-furo[3,2-d][1,3,2]dioxaphosphinin-2-one
54. (2s,4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-sulfide
55. (4ar,6r,7r,7as)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulanylidene-4a,6,7,7a-tetrahydro-4h-uro[3,2-d][1,3,2]dioxaphosphinin-7-ol
56. Rp1
Molecular Weight | 345.27 g/mol |
---|---|
Molecular Formula | C10H12N5O5PS |
XLogP3 | -0.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 1 |
Exact Mass | 345.02967667 g/mol |
Monoisotopic Mass | 345.02967667 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 502 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?